Search results

Page results

• Intrathecal Phenol

  This page has been written by the Spasticity Team at the National Hospital for Neurology and Neurosurgery.

• Intrathecal baclofen

  This page has been written by the Spasticity Team at the National Hospital for Neurology and Neurosurgery for patients (or their family or carers) who have been referred to our service or are under the care of the team at this hospital.

• World-first CJD treatment shows promising early results

  A world-first treatment for Creutzfeldt-Jakob disease (CJD) has shown “very encouraging” early results following its use in six patients at University College London Hospitals (UCLH) NHS Foundation Trust.

• MiniMed™ 780G Patient Webinars

  Medtronic are running a series of patient webinars for anyone with Type 1 Diabetes using the MiniMed™ 780G pump or system.

• Fibreoptic Endoscopic Evaluation of Swallow (FEES)

  Fibreoptic Endoscopic Evaluation of Swallow (FEES) patient information leaflet

• Staff and patients delighted with the newly refurbished Neurorehabilitation Unit

  The Neurorehabilitation Unit (NRU) at The National Hospital for Neurology and Neurosurgery (NHNN) has been refurbished with funding from The National Brain Appeal to provide new facilities and additional space, transforming it into a more therapeutic environment.

• Loss of smell a ‘highly specific’ indicator of Covid-19, finds UCLH and UCL research

  Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.

• UCLH top acute teaching trust in new national rankings

  We’re proud that UCLH is ranked number one of all acute teaching trusts in new national league tables published today.

• Age no criterion for decisions on heart attack treatment, new research finds

  Elderly patients suffering the most common type of heart attack may benefit from more invasive treatment, new research involving UCLH has shown.

• New precision therapy for bile duct cancer extends patients’ lives

  New precision therapy for bile duct cancer extends patients’ lives